Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05489965 · ClinicalTrials.gov registry record
Gender Disparities in Voice Outcomes After Tracheoesophageal Puncture in Total Laryngectomy Patients (UC Davis)
A clinical trial of Speech Disorders and Total Laryngectomy, sponsored by University of California, Davis.
- Recruiting
- Registry status
- 12
- Enrollment target
- 1
- Study location
NCT05489965 is a study of Speech Disorders and Total Laryngectomy that is actively recruiting participants, run by University of California, Davis. The registered enrollment target is 12 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05489965, a study of Speech Disorders and Total Laryngectomy, is actively recruiting participants, sponsored by University of California, Davis.
- RECRUITING
- Registry status
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
To perform a multi-site prospective study assessing, both subjectively and objectively, the gender disparities in speech outcomes of patients using TEP after total laryngectomy. The investigators hypothesize that speech outcomes, both subjective and objective measures, will be significantly poorer for female patients compared to male patients. The outcome of the study is to prospectively assess both subjective and objective gender disparities in voice and speech outcomes of patients using TEP after total laryngectomy across a multiple institutions. The investigators hypothesize that both subjective and objective measurements of voice, speech and quality of life will be poorer for female patients in comparison to male patients.
Conditions Studied
Study Locations (1)
California
- University of California San Diego - La Jolla
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2023-05-31 |
| Est. Completion | 2026-06-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05489965
The ClinicalTrials.gov registry entry for NCT05489965 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Speech Disorders appearing as the primary indexed condition, and to 0 interventions.
NCT05489965 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05489965 about?
NCT05489965 is a clinical study titled "Gender Disparities in Voice Outcomes After Tracheoesophageal Puncture in Total Laryngectomy Patients (UC Davis)". To perform a multi-site prospective study assessing, both subjectively and objectively, the gender disparities in speech outcomes of patients using TEP after total laryngectomy. The investigators hypothesize that speech outcomes, both subjective and objective measures, will be significantly poorer ...
What is the current status of trial NCT05489965?
This trial is currently recruiting. The enrollment target is 12 participants. The study started on 2023-05-31. Estimated completion is 2026-06-01.
What conditions does trial NCT05489965 study?
This clinical trial studies the following conditions: Speech Disorders, Total Laryngectomy, Speech Dysfunction, Laryngectomy; Status, Tracheoesophageal Prosthesis.
Who is sponsoring clinical trial NCT05489965?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05489965 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Speech Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.